Literature DB >> 9754891

Staged basilic vein transposition for dialysis angioaccess.

S El Mallah1.   

Abstract

BACKGROUND: To find out a suitable procedure to dissect an arterialised thick walled vein to create secondary angioaccess for dialysis. Delicacy of the vein wall, high rate of thrombosis and difficulty to find out a suitable vein are the main obstacles to vascular surgeons during the creation of secondary angioaccess.
METHODS: Forty patients in need for secondary angioaccess for dialysis were admitted for basilic vein transposition. They were classified randomly into two equal groups matched for age and sex. Group A patients were submitted to traditional basilic vein transposition. In group B, the operation was done in two stages. In the first stage, brachiobasilic anastomosis was done. Two to four weeks later the second stage was done to 19 patients (one patient had occluded shunt before the second stage) in the form of superficialization of the vein to be placed in the subcutaneous tissue.
RESULTS: Follow-up period for 6-24 months revealed that in the early postoperative period (4 weeks after operation) patency rate was 12/20 (60%) in group A and 18/20 (90%) with significant difference (p<0.05) between the two groups. Later, occlusion occurred in two patients in each group. At the end of the study the overall patency was 10/20 (50%) and 16/20 (80%) in group A and B respectively with significant difference between them. Both groups were similar in minor complications.
CONCLUSIONS: The staged basilic vein transposition is superior to the traditional operation in the patency rate and is recommended as a safe operation for a successful secondary angioaccess.

Entities:  

Mesh:

Year:  1998        PMID: 9754891

Source DB:  PubMed          Journal:  Int Angiol        ISSN: 0392-9590            Impact factor:   2.789


  8 in total

1.  Hemodialysis vascular access options after failed Brescia-Cimino arteriovenous fistula.

Authors:  Aneesh Srivastava; Sandeep Sharma
Journal:  Indian J Urol       Date:  2011-04

2.  Randomized controlled trial comparing primary and staged basilic vein transposition.

Authors:  Stavros K Kakkos; Ioannis A Tsolakis; Spyros I Papadoulas; George C Lampropoulos; Evangelos E Papachristou; Nikolaos C Christeas; Dimitrios Goumenos; Miltos K Lazarides
Journal:  Front Surg       Date:  2015-04-29

3.  Comparison of one- and two-stage basilic vein transposition for arterio-venous fistula formation in haemodialysis patients: preliminary results.

Authors:  Sedat Ozcan; Ali Kemal Gür; Ali Umit Yener; Dolunay Odabaşi
Journal:  Cardiovasc J Afr       Date:  2013 Oct-Nov       Impact factor: 1.167

Review 4.  One-stage vs. two-stage brachio-basilic arteriovenous fistula for dialysis access: a systematic review and a meta-analysis.

Authors:  Khalid Bashar; Donagh A Healy; Sawsan Elsheikh; Leonard D Browne; Michael T Walsh; Mary Clarke-Moloney; Paul E Burke; Eamon G Kavanagh; Stewart R Walsh
Journal:  PLoS One       Date:  2015-03-09       Impact factor: 3.240

5.  Review of Patency Rates between One-Stage and Two-Stage Brachial-Basilic Transposition Arteriovenous Fistulae Creation in an Asian Population.

Authors:  Hongyan Yu; Baoxian Huang; Joachim Wen Kien Yau; Sadhana Chandrasekar; Glenn Wei Leong Tan; Zhiwen Joseph Lo
Journal:  Ann Vasc Dis       Date:  2018-09-25

Review 6.  A Systematic Review and Meta-Analysis of Randomized Trials Comparing Two-Stage with One-Stage Brachio-Basilic Vein Fistulas.

Authors:  Stavros K Kakkos; George C Lampropoulos; Konstantinos M Nikolakopoulos; Ioannis A Tsolakis; Spyros I Papadoulas; Evangelos C Papachristou; Dimitrios Goumenos; Miltos K Lazarides
Journal:  Vasc Specialist Int       Date:  2018-09-30

7.  Transposed Brachial-Basilic Arteriovenous Fistula for Vascular Access in Japan.

Authors:  Juno Deguchi; Osamu Sato
Journal:  Ann Vasc Dis       Date:  2018-06-25

8.  Transposed Basilic Vein Fistula: A Credible Option.

Authors:  Benjamin Dk Leong; Ariffin A Zainal; Hussein Hanif; Hafizan M Tajri; Naresh Govindarajantran; Kumaraguru Pillay; Kia L Tan; Ahmad Faidzal Othman
Journal:  Ann Vasc Dis       Date:  2018-06-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.